Study of a new breathing machine plan for children with ARDS
Part of Lungs & breathing clinical trials.
This trial tests a new treatment plan for children with severe lung injury (ARDS) who are on a breathing machine. The goal is to find better ways to manage their breathing support and improve their recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 weeks old (born at least 38 weeks) and 18 years old.
- They must be on a breathing machine (ventilator) with a tube in their windpipe for less than 7 days.
- They must have low oxygen levels in their blood and cloudy spots on both sides of their lung X-ray.
- Their breathing problem must not be caused by heart failure or fluid overload.
- Doctors must expect them to live more than 3 days, and you must be open to all available treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how severe breathing difficulty (dyspnea) affects the recovery of children with a lung condition called acute respiratory distress syndrome (ARDS). It aims to improve care by tracking symptoms over time.
This trial tests a new way to adjust the amount of air given by the ventilator to people with a severe lung injury called ARDS. The goal is to see if a specific breathing strategy can help protect the lungs and improve recovery.
This trial studies two ways to measure how much of your lungs can open up again (recruitability) to help doctors set the best breathing machine pressure. It may help improve oxygen levels in patients with severe lung injury.
This study looks at how the level of pressure from a breathing machine affects blood flow back to the heart in people with severe lung injury (ARDS). It may help doctors find the best settings to protect your heart while helping your lungs.
This study compares a more careful ventilation approach for people with severe lung breathing failure (ARDS). It aims to improve outcomes by using a specific strategy for how the ventilator controls breathing.
This trial tests a computer “decision support” tool to help the care team manage treatment for children with PARDS who are just starting a breathing machine. It may help clinicians choose care steps and potentially support safer, more effective breathing management during the first days of ventilation.
Hear when a new Lung Protective Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.